Sean Smith
No más puestos en curso
Perfil
Sean Smith worked as a Senior Manager-Accounting at Aptevo Therapeutics, Inc. from 2017 to 2019.
He also worked as Vice President-Finance & Controller at Neoleukin Therapeutics, Inc. in 2022 and 2023.
Mr. Smith holds an MBA from the University of Washington and completed his undergraduate and graduate studies at the University of North Texas.
Antiguos cargos conocidos de Sean Smith.
| Empresas | Cargo | Fin |
|---|---|---|
| APTEVO THERAPEUTICS INC. | Comptroller/Controller/Auditor | 01/08/2019 |
| NEUROGENE INC. | Director of Finance/CFO | - |
Formación de Sean Smith.
| University of Washington | Masters Business Admin |
| University of North Texas | Graduate Degree |
Experiencias
Funciones ocupadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| APTEVO THERAPEUTICS INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Neoleukin Therapeutics, Inc.
 Neoleukin Therapeutics, Inc. BiotechnologyHealth Technology Neoleukin Therapeutics, Inc. operates as a biopharmaceutical company, which computational methods to design de novo protein therapeutics. The firm address significant medical needs in oncology, inflammation, and autoimmunity. Its lead product candidate, NL-201, is a combined IL-2 and IL-15 agonist designed to eliminate alpha receptor binding. The company was founded by Daniel-Adriano Silva, Carl Walkey, and Umut Ulge in December 2003 and is headquartered in Seattle, WA. | Health Technology |
- Bolsa de valores
- Insiders
- Sean Smith
